Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Carcinosarcoma of the ovary.

Silasi DA, Illuzzi JL, Kelly MG, Rutherford TJ, Mor G, Azodi M, Schwartz PE.

Int J Gynecol Cancer. 2008 Jan-Feb;18(1):22-9. Epub 2007 Apr 19.

PMID:
17451459
2.

Carcinosarcoma of the ovary: analysis of 13 cases and review of the literature.

Loizzi V, Cormio G, Camporeale A, Falagario M, De Mitri P, Scardigno D, Putignano G, Selvaggi LE.

Oncology. 2011;80(1-2):102-6. doi: 10.1159/000328794. Epub 2011 Jun 14. Review.

PMID:
21677454
3.

[Chemotherapy in the treatment of ovarian carcinosarcoma].

Melilli GA, Di Vagno G, Cormio G, Greco P, Fontana A, Carriero C, Loverro G, Selvaggi L.

Minerva Ginecol. 1999 Nov;51(11):445-8. Review. Italian.

PMID:
10726444
4.

Advanced ovarian cancer.

van der Burg ME.

Curr Treat Options Oncol. 2001 Apr;2(2):109-18. Review.

PMID:
12057129
5.

[Carcinosarcoma of the ovary treated with paclitaxel and carboplatin chemotherapy - a report of 4 cases].

Otsuka I, Takaya H, Takagi K, Tanaka A, Kaseki H, Izuta C, Sato M, Matsuura T, Suzuki Y.

Gan To Kagaku Ryoho. 2013 Sep;40(9):1249-53. Review. Japanese.

PMID:
24047791
6.

Primary ovarian carcinosarcoma: a case report and review of the literature.

Varras M, Akrivis Ch, Antoniou N, Tolis C, Stefanaki S, Salamalekis E.

Eur J Gynaecol Oncol. 2004;25(5):653-6. Review.

PMID:
15493190
7.

Recent advances in the management of women with ovarian cancer.

Eltabbakh GH.

Minerva Ginecol. 2004 Feb;56(1):81-9. Review.

PMID:
14973412
8.

Diagnosis and management of epithelial ovarian cancer.

Bhoola S, Hoskins WJ.

Obstet Gynecol. 2006 Jun;107(6):1399-410. Review.

PMID:
16738170
9.

[Drug therapy of ovarian carcinoma].

Dittrich C.

Wien Med Wochenschr. 1996;146(1-2):23-34. Review. German.

PMID:
8835492
10.

[Prognostic factors of ovarian cancer].

Ochiai K.

Gan To Kagaku Ryoho. 2006 Dec;33(13):2014-9. Review. Japanese.

PMID:
17197745
11.

[First line chemotherapy for advanced ovarian cancer in 2000: standards and questions].

Cure H, Dauplat J, Cholet P.

Bull Cancer. 2000 Feb;87(2):189-99. Review. French.

12.

Future directions for paclitaxel (TAXOL) in the treatment of ovarian cancer.

Bookman MA, Ozols RF.

Semin Oncol Nurs. 1993 Nov;9(4 Suppl 2):21-9. Review.

PMID:
7904377
13.

Ovarian cancer.

Ozols RF.

Semin Surg Oncol. 1990;6(6):328-38. Review.

PMID:
2263808
14.

Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?

Petignat P, du Bois A, Bruchim I, Fink D, Provencher DM.

Crit Rev Oncol Hematol. 2007 May;62(2):137-47. Epub 2006 Dec 26. Review.

PMID:
17188887
15.
16.

Critical evaluation of secondary cytoreduction in recurrent ovarian cancer.

Munkarah AR, Coleman RL.

Gynecol Oncol. 2004 Nov;95(2):273-80. Review.

PMID:
15491746
17.

[A case and literature review of ovarian carcinosarcoma with long-term survival after repeated recurrences].

Asano M, Hasegawa K, Tsukada K, Tada S, Mizoguchi Y, Imaeda Y, Ikeda M, Kawamura K, Fujii T.

Gan To Kagaku Ryoho. 2014 Aug;41(8):1031-6. Review. Japanese.

PMID:
25132040
18.

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.

Berton-Rigaud D, Devouassoux-Shisheboran M, Ledermann JA, Leitao MM, Powell MA, Poveda A, Beale P, Glasspool RM, Creutzberg CL, Harter P, Kim JW, Reed NS, Ray-Coquard I.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S55-60. doi: 10.1097/IGC.0000000000000228. Review.

PMID:
25341582
19.

[Current status and prospects of chemotherapy of ovarian cancer].

Sen K, Lang JH, Lian LJ.

Zhonghua Fu Chan Ke Za Zhi. 1994 Dec;29(12):753-7. Review. Chinese. No abstract available.

PMID:
7712905
20.

Advanced ovarian carcinoma as a chronic disease: a case report and review.

Natarajan M, Saravanan SM, Elson DL.

S D J Med. 2003 Dec;56(12):515-21. Review.

PMID:
14733039

Supplemental Content

Support Center